A Phase I, Randomized, Placebo-Controlled, Dose Escalating Cross Over Study To Evaluate The Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of PF-05105679 Under Fasted Conditions In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2011
At a glance
- Drugs Oxycodone; PF 5105679
- Indications Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Acronyms SINGLE DOSE
- 30 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2011 New trial record